Our API R&D function has more than two decades of experience in developing intermediates and APIs which resulted in the commercialization of more than 200 APIs along with their intermediates till date. Aurobindo's API R&D has its experience in developing molecules across various product categories like Penicillin's, Cephalosporins along with non betalactam products.

Aurobindo's expertise and experience lie in developing molecules across various therapeutics such as Anti-virals, Anti-diabetics, CNS, CVS, Anti-retrovirals, Anti-infectives, etc. This is clear from the fact that Aurobindo is one of the world leaders in ARV development and supply.